HIGHLIGHTS
- who: Renata G. J. Gonu00e7alves from the University of Warwick, United Kingdom have published the article: Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases, in the Journal: (JOURNAL)
- what: The aim of this study is to evaluate the safety and feasibility of different doses of allogeneic BM-MSCs, injected intravenously or intraventricularly in the acute phase of hemorrhagic stroke.
- future: Despite the encouraging results described above further studies are necessary to validate the efficacy of MSC therapy especially in hemorrhagic stroke. Considering those aspects new preclinical studies have shown . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.